ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 84 filers reported holding ADICET BIO INC in Q3 2023. The put-call ratio across all filers is 7.96 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,530 | -52.1% | 59,511 | -15.0% | 0.00% | – |
| Q2 2023 | $170,073 | -70.3% | 69,989 | -29.5% | 0.00% | – |
| Q1 2023 | $572,002 | -77.8% | 99,306 | -65.5% | 0.00% | -100.0% |
| Q4 2022 | $2,576,749 | -54.1% | 288,227 | -27.0% | 0.00% | 0.0% |
| Q3 2022 | $5,618,000 | +11.4% | 395,081 | +14.3% | 0.00% | 0.0% |
| Q2 2022 | $5,045,000 | +10.8% | 345,547 | +51.5% | 0.00% | 0.0% |
| Q1 2022 | $4,554,000 | +59.2% | 228,031 | +39.4% | 0.00% | 0.0% |
| Q4 2021 | $2,861,000 | +860.1% | 163,625 | +330.4% | 0.00% | – |
| Q3 2021 | $298,000 | +86.2% | 38,016 | +144.2% | 0.00% | – |
| Q2 2021 | $160,000 | -73.2% | 15,565 | -66.0% | 0.00% | – |
| Q1 2021 | $598,000 | +315.3% | 45,755 | +346.8% | 0.00% | – |
| Q4 2020 | $144,000 | – | 10,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |